EA201891726A1 - Лиганды для pet-визуализации тау-белков - Google Patents
Лиганды для pet-визуализации тау-белковInfo
- Publication number
- EA201891726A1 EA201891726A1 EA201891726A EA201891726A EA201891726A1 EA 201891726 A1 EA201891726 A1 EA 201891726A1 EA 201891726 A EA201891726 A EA 201891726A EA 201891726 A EA201891726 A EA 201891726A EA 201891726 A1 EA201891726 A1 EA 201891726A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- compounds
- tau proteins
- pet
- ligands
- visualization
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/041—Heterocyclic compounds
- A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K51/0455—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
- C07B59/002—Heterocyclic compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/05—Isotopically modified compounds, e.g. labelled
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Optics & Photonics (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Nuclear Medicine (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Настоящее изобретение относится к новым селективным, меченным радиоактивным изотопом лигандам тау-белков, которые являются пригодными для визуализации и количественного определения агрегатов тау-белков с применением позитронно-эмиссионной томографии (PET). Настоящее изобретение также направлено на композиции, содержащие такие соединения, на способы получения таких соединений и композиций, на применение таких соединений и композиций для визуализации ткани или субъекта, in vitro или in vivo, и на предшественники указанных соединений.
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP16154123 | 2016-02-03 | ||
EP16161466 | 2016-03-21 | ||
EP16183009 | 2016-08-05 | ||
EP16186603 | 2016-08-31 | ||
PCT/EP2017/052143 WO2017134098A1 (en) | 2016-02-03 | 2017-02-01 | Tau pet imaging ligands |
Publications (2)
Publication Number | Publication Date |
---|---|
EA201891726A1 true EA201891726A1 (ru) | 2018-12-28 |
EA035621B1 EA035621B1 (ru) | 2020-07-16 |
Family
ID=57963206
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201891726A EA035621B1 (ru) | 2016-02-03 | 2017-02-01 | Лиганды для pet-визуализации тау-белков |
Country Status (9)
Country | Link |
---|---|
US (2) | US20190038784A1 (ru) |
EP (1) | EP3411083A1 (ru) |
JP (1) | JP6966456B2 (ru) |
AU (1) | AU2017216212B2 (ru) |
CA (1) | CA3010690A1 (ru) |
EA (1) | EA035621B1 (ru) |
IL (1) | IL260862B (ru) |
MA (1) | MA43954A (ru) |
WO (1) | WO2017134098A1 (ru) |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8318132B2 (en) * | 2008-02-14 | 2012-11-27 | Siemens Medical Solutions Usa, Inc. | Imaging agents for detecting neurological dysfunction |
CN103739605B (zh) * | 2009-03-23 | 2016-08-17 | 伊莱利利公司 | 用于检测神经障碍的显像剂 |
CN106928194B (zh) * | 2009-06-12 | 2019-11-12 | Abivax公司 | 用于治疗过早衰老和尤其是早衰的化合物 |
US9138494B2 (en) * | 2011-12-23 | 2015-09-22 | Abbvie Inc. | Radiolabeled PDE10A ligands |
WO2015110263A1 (en) * | 2014-01-21 | 2015-07-30 | Ac Immune Sa | Carbazole and carboline compounds for use in the diagnosis, treatment, alleviation or prevention of disorders associated with amyloid or amyolid-like proteins |
-
2017
- 2017-02-01 EP EP17703109.3A patent/EP3411083A1/en active Pending
- 2017-02-01 WO PCT/EP2017/052143 patent/WO2017134098A1/en active Application Filing
- 2017-02-01 JP JP2018540455A patent/JP6966456B2/ja active Active
- 2017-02-01 EA EA201891726A patent/EA035621B1/ru not_active IP Right Cessation
- 2017-02-01 MA MA043954A patent/MA43954A/fr unknown
- 2017-02-01 US US16/073,992 patent/US20190038784A1/en not_active Abandoned
- 2017-02-01 CA CA3010690A patent/CA3010690A1/en not_active Abandoned
- 2017-02-01 AU AU2017216212A patent/AU2017216212B2/en active Active
-
2018
- 2018-07-30 IL IL260862A patent/IL260862B/en active IP Right Grant
-
2021
- 2021-04-30 US US17/246,184 patent/US20210283277A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
AU2017216212A1 (en) | 2018-07-19 |
EA035621B1 (ru) | 2020-07-16 |
CA3010690A1 (en) | 2017-08-10 |
WO2017134098A1 (en) | 2017-08-10 |
US20210283277A1 (en) | 2021-09-16 |
US20190038784A1 (en) | 2019-02-07 |
JP6966456B2 (ja) | 2021-11-17 |
JP2019511461A (ja) | 2019-04-25 |
AU2017216212B2 (en) | 2020-12-24 |
MA43954A (fr) | 2018-12-12 |
EP3411083A1 (en) | 2018-12-12 |
IL260862B (en) | 2021-05-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA202091710A1 (ru) | Антитела против cd73 и способы их применения | |
EA201690862A1 (ru) | Соединения для позитронно-эмиссионной томографии | |
EA201790407A1 (ru) | Зонды для визуализации белка хантингтина | |
EA201100301A1 (ru) | Daa-пиридин в качестве лиганда периферического бензодиазепинового рецептора для диагностической визуализации и фармацевтического лечения | |
MX2022014914A (es) | Compuestos de interaccion con glicanos y metodos de uso. | |
EA201791733A1 (ru) | Производные 9h-пирролодипиридина | |
BR112017010414A2 (pt) | métodos e composições para radiomarcação com 18f de substâncias biológicas | |
MA34057B1 (fr) | Compositions et methodes pour le diagnostic et le traitement d'une tumeur | |
EA201500835A1 (ru) | Терапевтическая и диагностическая мишень для рака, включающая dll3-связывающие реагенты | |
EA201891444A1 (ru) | ЛИГАНДЫ mGluR2/3 ДЛЯ PET, МЕЧЕННЫЕ РАДИОАКТИВНЫМИ ИЗОТОПАМИ | |
EA201691541A1 (ru) | Новые анти-baff антитела | |
CY1124935T1 (el) | Ραδιοσημασμενα mglur2/3 προσδεματα για pet | |
SG194761A1 (en) | Radiolabeled amino acids for diagnostic imaging | |
EA201890221A1 (ru) | Hbed-бисфосфонаты, их конъюгаты с радиометаллом и их применение в качестве лечебно-диагностических агентов | |
EA201790400A1 (ru) | Зонды для визуализации белка хантингтина | |
EA200901142A1 (ru) | 18f фторбензоильные меченые биологически активные соединения в качестве диагностических визуализирующих средств, а также бензотриазол-1-илоксибензоильные, 2,5-(диоксопирролидин-1-илокси)бензоильные и триметиламмониобензоильные предшественники | |
MX2021013251A (es) | Tintes de cianina modificados y conjugados de los mismos. | |
WO2017105565A3 (en) | Compositions for therapeutics, targeted pet imaging and methods of their use | |
EA201290245A1 (ru) | Радиоактивно меченные pde10 лиганды | |
MY196981A (en) | Compounds for imaging tau protein aggregates | |
EA201501175A1 (ru) | Новые соединения для лечения злокачественного новообразования | |
EA202091766A1 (ru) | Композиции для диагностики для пэт-визуализации, способ получения композиции для диагностики и ее применение в диагностике | |
EA201790336A1 (ru) | Антитела к ангиопоэтинподобному белку 4 и способы применения | |
CO6341628A2 (es) | \\\\\\\"nuevos compuestos adecuados como precursores de compuestos que son utiles para obtener imegenes de depositos amiloides\\\\\\\" | |
SV2009003205A (es) | Derivados de silicio para obtencion de imagenes por tomografia de emision de positrones (pet) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): AM AZ BY KZ KG TJ TM |